Everence Capital Management Inc. Makes New $222,000 Investment in Schrödinger, Inc. (NASDAQ:SDGR)

Everence Capital Management Inc. bought a new position in shares of Schrödinger, Inc. (NASDAQ:SDGR) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 6,200 shares of the company’s stock, valued at approximately $222,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Envestnet Asset Management Inc. bought a new position in shares of Schrödinger during the first quarter worth about $312,000. US Bancorp DE grew its position in shares of Schrödinger by 69.2% during the first quarter. US Bancorp DE now owns 1,932 shares of the company’s stock worth $66,000 after acquiring an additional 790 shares during the last quarter. MetLife Investment Management LLC grew its position in shares of Schrödinger by 58.5% during the first quarter. MetLife Investment Management LLC now owns 25,484 shares of the company’s stock worth $870,000 after acquiring an additional 9,405 shares during the last quarter. Rhumbline Advisers grew its position in shares of Schrödinger by 2.5% during the first quarter. Rhumbline Advisers now owns 46,592 shares of the company’s stock worth $1,590,000 after acquiring an additional 1,141 shares during the last quarter. Finally, BlackRock Inc. grew its position in shares of Schrödinger by 2.6% during the first quarter. BlackRock Inc. now owns 3,205,108 shares of the company’s stock worth $109,357,000 after acquiring an additional 81,435 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Schrödinger Trading Down 0.2 %

NASDAQ:SDGR opened at $24.29 on Friday. Schrödinger, Inc. has a twelve month low of $20.76 and a twelve month high of $59.24. The company has a 50-day moving average of $27.26 and a 200-day moving average of $28.37. The firm has a market cap of $1.76 billion, a price-to-earnings ratio of 38.56 and a beta of 1.57.

Schrödinger (NASDAQ:SDGR) last posted its quarterly earnings data on Wednesday, February 28th. The company reported ($0.32) EPS for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.12. Schrödinger had a net margin of 18.79% and a negative return on equity of 23.58%. The company had revenue of $74.10 million during the quarter, compared to analyst estimates of $79.12 million. During the same period in the prior year, the firm earned ($0.39) earnings per share. The business’s quarterly revenue was up 30.5% on a year-over-year basis. On average, research analysts forecast that Schrödinger, Inc. will post -2.73 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Bank of America lowered their price target on shares of Schrödinger from $38.00 to $32.00 and set a “neutral” rating for the company in a research report on Thursday, February 29th. Citigroup lowered their price target on shares of Schrödinger from $47.00 to $39.00 and set a “buy” rating for the company in a research report on Thursday, February 29th. TD Cowen initiated coverage on shares of Schrödinger in a research report on Friday, January 26th. They issued an “outperform” rating and a $42.00 target price for the company. KeyCorp decreased their target price on shares of Schrödinger from $38.00 to $33.00 and set an “overweight” rating for the company in a research report on Thursday, February 29th. Finally, The Goldman Sachs Group decreased their target price on shares of Schrödinger from $29.00 to $26.00 and set a “neutral” rating for the company in a research report on Friday, March 1st. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, Schrödinger has an average rating of “Moderate Buy” and an average price target of $43.50.

Insider Buying and Selling at Schrödinger

In other Schrödinger news, insider Robert Lorne Abel sold 1,205 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $27.55, for a total transaction of $33,197.75. Following the completion of the sale, the insider now directly owns 9,340 shares of the company’s stock, valued at $257,317. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, COO Kenneth Patrick Lorton sold 901 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $28.29, for a total value of $25,489.29. Following the completion of the sale, the chief operating officer now directly owns 36,487 shares of the company’s stock, valued at $1,032,217.23. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Robert Lorne Abel sold 1,205 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $27.55, for a total transaction of $33,197.75. Following the completion of the sale, the insider now directly owns 9,340 shares of the company’s stock, valued at $257,317. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 3,651 shares of company stock valued at $102,395. 7.60% of the stock is currently owned by corporate insiders.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.